Your patents are not just legal protection.
They're a commercial tool. Here's how to use them.

Ask a deeptech founder what their patents do for them commercially, and you'll usually get one of two answers. Either "they protect our technology" or "they help with due diligence." Both are true. Neither is the full picture.

Industrial buyers read IP portfolios differently from lawyers and differently from investors. Understanding how they read yours — and structuring your portfolio and your conversations accordingly — is one of the most underused levers in deeptech commercial development.

How industrial buyers actually read your IP

When an industrial director or a corporate legal team looks at your IP portfolio, they are not primarily asking "is this well-protected?" They are asking three other questions, and your answers to them shape the entire commercial conversation that follows.

Is this real? A startup claiming a breakthrough with no filed IP is a startup that hasn't yet committed to its own technology — at least not in any verifiable, public form. Patents, even at the provisional stage, signal that you believe in what you've built enough to invest in protecting it. That credibility signal operates before a single technical conversation has happened, and it opens doors that no pitch deck alone can open.

What exactly does this cover? Patent claims define the commercial perimeter of your technology. An industrial buyer evaluating a potential collaboration will use your claims to understand what they can and can't do with or around your technology — whether they could develop something adjacent without creating a conflict, whether a collaboration gives their own work meaningful protection, and whether there are freedom-to-operate risks on their side that their legal team will flag. A clear, well-scoped claim set makes that assessment possible. A vague or overly broad portfolio makes it feel uncertain and risky.

What's available? A well-structured IP portfolio with clearly scoped application claims creates commercial opportunities that most founders don't exploit. If your patents cover three distinct applications in different industrial sectors, you can engage three different industrial partners simultaneously — without conflict, without exclusivity issues, and with each partner feeling they have a protected and differentiated lane. This is a commercial architecture, not just a legal one.

Using patent claims to define your commercial positioning

The structure of your patent claims is not purely a legal decision. It is a commercial one, and it should be made with commercial conversations in mind.

Broad claims cover more territory but are harder to defend and often don't survive challenge. Narrow, specific claims are more defensible — and crucially, more legible to commercial partners. A claim that covers a specific process applied to a specific material class in a specific operating range tells an industrial buyer exactly what they're getting access to. A claim that covers "all methods of detection in biological samples" tells them very little they can act on.

Before entering commercial conversations, map your IP to your target applications. Which claims are relevant to which industrial sectors? Which applications are clearly covered and which remain unprotected? Where is your freedom to operate solid and where are there potential conflicts? This mapping has two immediate uses: it enables honest, specific conversations about what you can offer each partner, and it reveals the claims that are most commercially valuable — which may not be the ones that are technically most impressive.

The SRA and licensing conversation

The most direct commercial use of your IP is in structuring collaboration agreements. Sponsored research agreements, option agreements, and partial licences all revolve around one central question: what rights does the partner get, over what scope, for what duration, and on what terms?

If you don't understand your own IP scope well enough to answer these questions specifically, you cannot negotiate these agreements effectively. And the most common — and costly — mistake in early partnership negotiations is agreeing to a scope that is too broad. Founders who accept an SRA with overly wide IP rights can find, years later, that they've unknowingly transferred rights over applications they wanted to develop independently with other partners.

The protection runs the other way too. A clear, narrow IP scope makes your offer more commercially attractive to a sophisticated industrial partner, not less. "We can offer you an exclusive option on this specific application in this geographic territory, while retaining full freedom to develop these three other applications independently" is a far more actionable and trustworthy offer than "we'd like to explore licensing our technology." It tells the partner exactly what they're getting and — just as importantly — that you've thought carefully about what you're not giving away.

Opening a commercial conversation with IP

There is a tactic that experienced deeptech commercial developers use regularly and most early-stage founders don't: starting the approach with IP rather than with a pitch.

It works like this. Rather than approaching a potential industrial partner with "here is our technology and why it's relevant to you," you open with "we've been working in this application area and have filed IP covering these specific aspects — we'd be interested to understand whether there's any technical overlap or complementarity with your current work, and whether an exchange of views would be useful."

This framing does several things simultaneously. It positions you as a peer — someone who has invested in the field, not just an optimistic founder with a pitch. It creates a legitimate, bilateral reason for the other party to engage, even if they don't yet see a clear commercial opportunity. And it initiates a conversation that is naturally technical and collegial, rather than a one-way commercial approach that triggers the defensive response most industrial buyers have developed to unsolicited pitches.

Some of the most valuable early relationships in deeptech commercial development begin in exactly this mode — not as commercial discussions, but as technical conversations between parties who are both invested in the same space. The commercial conversation follows naturally, once the relationship has been established.

What a commercially structured IP portfolio looks like

A portfolio designed with commercial conversations in mind has four properties.

It covers a defined application scope — not everything you might eventually do, but the specific areas where your technology has a demonstrable and defensible advantage today. It is mapped to industrial sectors and use cases in language that a non-lawyer can read and understand. It has a clear freedom-to-operate position on your core application, so you can engage partners without unexpected complications arising from their legal review. And it has been filed in the jurisdictions where your target partners actually operate — which is often not the same as where you are headquartered.

You don't need to build this overnight, and you don't need to have resolved every IP question before starting commercial conversations. But building your portfolio with commercial conversations in mind — rather than purely with legal defence in mind — changes the decisions you make along the way. Which applications to cover first. Which claims to pursue. Which jurisdictions to prioritise. Which agreements to avoid.

IP is one of the few assets a deeptech startup can build during R&D that has immediate, tangible commercial value. Most founders treat it as a cost centre and a legal necessity. The founders who close early partnerships consistently treat it as something else: an active commercial tool, built and deployed with intention.